Internal Medicine · Bellevue, WA
NPI
1992807499
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1750 112th Ave NE, Build 4 D-160
Bellevue, WA, 98004
Phone (425) 637-2340
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
252 services
Medicare patients, 2024
67
Average age 78
Drug cost, 2024
$1.2M
12,820 prescriptions
Company payments, 2025
$1,444
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tatyana Kutsy was code 99214 (office e&m - established), 91 times for 43 patients. In total Tatyana Kutsy billed 252 services in 11 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 91 | 43 | $90.29 | $8,217 |
| 99213 Office E&M - Established | Office | 57 | 44 | $57.66 | $3,287 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 26 | 26 | $142.70 | $3,710 |
| 36415 Venipuncture Blood Collection | Office | 16 | 14 | $8.65 | $138 |
By year: 2022 $36K for 512 services; 2023 $27K for 367 services; 2024 $19K for 252 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 16 | 14 | $8.65 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Tatyana Kutsy prescribed most often to Medicare patients was Omeprazole, with 507 prescriptions and refills. In total Tatyana Kutsy wrote 12,820 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 507 | 776 | 87 | $7,563 |
| Lisinopril Generic | 352 | 714 | 77 | $2,443 |
| Atorvastatin Calcium Generic | 348 | 762 | 79 | $2,226 |
| Metformin Hcl Generic | 338 | 664 | 62 | $1,980 |
| Fluticasone Propionate Generic | 311 | 364 | 45 | $4,490 |
| Tizanidine Hcl Generic | 311 | 325 | 46 | $2,219 |
| Hydrochlorothiazide Generic | 300 | 590 | 62 | $1,115 |
| Amlodipine Besylate Generic | 293 | 589 | 68 | $1,841 |
| Diclofenac Sodium Generic | 271 | 282 | 40 | $22K |
| Meloxicam Generic | 265 | 316 | 42 | $964 |
| Meclizine Hcl Generic | 248 | 252 | 40 | $3,442 |
| Losartan Potassium Generic | 236 | 503 | 52 | $1,805 |
| Rosuvastatin Calcium Generic | 228 | 541 | 56 | $2,375 |
| Levothyroxine Sodium Generic | 224 | 505 | 41 | $1,524 |
| Metoprolol Succinate Generic | 211 | 362 | 37 | $1,705 |
Brand drugs: 1,615 claims; generic drugs: 11,033 claims; opioid claims: 242.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tatyana Kutsy $1,444 ($1,444 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $413.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $413 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $175 |
| Kowa Pharmaceuticals America, Inc. | 4 | $122 |
| Novo Nordisk Inc NVO | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $104 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $91.49 |
| Aimmune Therapeutics, Inc. | 5 | $89.71 |
| Lundbeck LLC | 3 | $74.9 |
| Amgen Inc. AMGN | 2 | $46.55 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $46.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.